Freyr Battery (NYSE:FREY) has informed officials in a suburban Atlanta county that it won’t proceed with a $2.6B plant, the Newnan Times Herald reported Thursday. According to the report, the ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

One leading theory on the origins of life on Earth proposes that simple chemical molecules gradually became more complex, ...

Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...

By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia - a bulge that results from soft tissue pushing through a weak spot in the abdominal muscles.

By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia—a bulge that results from soft tissue pushing through a ...

Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

J&J, AstraZeneca, Novo Nordisk and Roche are among the companies that might take a hit from the soon-to-be-enacted fees, ...

Chronic stress is linked to a weakened immune system and increased cancer diagnosis risk, though psychological factors alone ...

It's not the only blood pressure medication recall to happen in recent months, but the FDA's concern appears to follow a common theme.